NNOX Nano-X Imaging Ltd.
USHealthcareAs of 2026-07-09 16:00
Why NNOX matters now
Nano-X Imaging Ltd. (NNOX) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.17 with -3.31% on the session and $81.4M in market capitalization; recent performance reads 1-month -3.47% and YTD -40.36%.
The latest financial table shown here is Q4 2025, with revenue of $3.7M, net income of $-33.4M, and EPS of $-0.50. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -41.0%.
The latest indexable market news headline is "NNOX Investors Have Rights – If You Lost Money Investing in Nano-X Imaging Ltd. Contact Robbins LLP for Information About Recovering Your Losses" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $18.00; recent insider activity includes Alroy Erez filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.80
P/S
8.93
EV/EBITDA
-1.53
DCF Value
$-5.72
FCF Yield
-41.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
-98.2%
Operating Margin
-466.2%
Net Margin
-576.1%
ROE
-47.1%
ROA
-46.3%
ROIC
-39.7%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $3.7M | $-33.4M | $-0.50 |
| FY 2025 | $13.0M | $-75.0M | $-1.16 |
| Q3 2025 | $3.4M | $-13.7M | $-0.21 |
| Q2 2025 | $3.0M | $-14.7M | $-0.23 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$18.00
Target (Median)
$18.00
Target Range
$18.00 - $18.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
IL
Exchange
—
Beta
1.17
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.